Furthermore, increased signalling mediated by the PI3K/AKT pathway, achieved via mutations in PIK3CA or loss of PTEN expression are not mutually exclusive, suggesting that independent growth advantages are provided by these two cancer promoting changes in colorectal cancer. The gene discussed is AKT1; the disease is colorectal cancer.